Literature DB >> 21625988

Clonidine extended release in the treatment of attention-deficit/hyperactivity disorder.

Mathew Nguyen1, Kimberly A White, Regina Bussing.   

Abstract

Entities:  

Year:  2011        PMID： 21625988     DOI： 10.1007/s11920-011-0209-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  4 in total

1.  Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.

Authors:  J B Prince; T E Wilens; J Biederman; T J Spencer; J R Wozniak
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-05       Impact factor: 8.829

2.  Clonidine in child and adolescent psychiatry.

Authors:  R D Hunt; L Capper; P O'Connell
Journal:  J Child Adolesc Psychopharmacol       Date:  1990       Impact factor: 2.576

3.  Clonidine treatment of Gilles de la Tourette's syndrome.

Authors:  J F Leckman; M T Hardin; M A Riddle; J Stevenson; S I Ort; D J Cohen
Journal:  Arch Gen Psychiatry       Date:  1991-04

4.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.